Question 1

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma clinical trial (NCT04209686). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination compare to other treatment options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma clinical trial (NCT04209686). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma clinical trial (NCT04209686). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma clinical trial (NCT04209686). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses while I am in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma clinical trial (NCT04209686). Contact the study team or your healthcare provider for specific answers.

What this study is about